Brain and gut CRF signaling: Biological actions and role in the gastrointestinal tract

Current Molecular Pharmacology

Volumn 11, Issue 1, 2018, Pages 51-71

  Taché, Yvette ^a   Larauche, Muriel ^a   Yuan, Pu Qing ^a   Million, Mulugeta ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CRF peptides; CRF receptor antagonists; Gut secreto motor function; Irritable bowel syndrome; Stress; Visceral pain

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; 4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 [N ETHYL N (4 ISOPROPYL 2 METHYLTHIOPHENYL)AMINO] 6 METHYLPYRIMIDINE; 5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; 8 (2,4 DICHLOROPHENYL) 4 [2 METHOXY 1 (METHOXYMETHYL)ETHYLAMINO] 2,7 DIMETHYLPYRAZOLO[1,5 A][1,3,5]TRIAZINE; ALPHA HELICAL CORTICOTROPIN RELEASING FACTOR [9-41]; ANTALARMIN; ANTISAUVAGINE 30; ASTRESSIN; BICARBONATE; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; EMICERFONT; JTC 017; NBI 30545; NBI 35965; NGD 9002; NGD 98 2; PEXACERFONT; R 317573; UNCLASSIFIED DRUG; UROCORTIN;

BRAIN FUNCTION; BRAIN REGION; CORTICOTROPIN RELEASE; DRUG MECHANISM; ENZYME ACTIVATION; FUNCTIONAL DISEASE; GASTROINTESTINAL TRACT; HUMAN; HYPERALGESIA; INFLAMMATORY BOWEL DISEASE; INTESTINAL SECRETION; INTESTINE FUNCTION; IRRITABLE COLON; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STOMACH ACID SECRETION; STOMACH FUNCTION; STOMACH MOTILITY; TREATMENT OUTCOME; VISCERAL AFFERENT NERVE; VISCERAL PAIN; WATER ABSORPTION; ANIMAL; BRAIN; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY;

ANIMALS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; GASTROINTESTINAL TRACT; HUMANS; MOTOR ACTIVITY; SIGNAL TRANSDUCTION;

EID: 85041842499     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467210666170224095741     Document Type: Review

References (301)

1. Guillemin, R. Neuroendocrinology: a short historical review. Ann. N. Y. Acad. Sci., 2011, 1220, 1-5.
2. Bale, T.L.; Chen, A. Minireview: CRF and Wylie Vale: a story of 41 amino acids and a Texan with grit. Endocrinology, 2012, 153, 2556-2561.
3. Vale, W.; Spiess, J.; Rivier, C.; Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and b-endorphin. Science, 1981, 213, 1394-1397.
4. Vaughan, J.; Donaldson, C.; Bittencourt, J.; Perrin, M. H.; Lewis, K.; Sutton, S.; Chan, R.; Turnbull, A.V.; Lovejoy, D.; Rivier, C.; Rivier, J.; Sawchenko, P.E.; Vale, W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature, 1995, 378, 287-292.
5. Reyes, T.M.; Lewis, K.; Perrin, M.H.; Kunitake, K.S.; Vaughan, J.; Arias, C.A.; Hogenesch, J.B.; Gulyas, J.; Rivier, J.; Vale, W.W.; Sawchenko, P.E. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. USA, 2001, 98, 2843-2848.
6. Hsu, S.Y.; Hsueh, A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med., 2001, 7, 605-611.
7. Lewis, K.; Li, C.; Perrin, M.H.; Blount, A.; Kunitake, K.; Donaldson, C.; Vaughan, J.; Reyes, T.M.; Gulyas, J.; Fischer, W.; Bilezikjian, L.; Rivier, J.; Sawchenko, P.E.; Vale, W.W. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A., 2001, 98, 7570-7575.
8. Chen, R.; Lewis, K.A.; Perrin, M.H.; Vale, W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. U.S.A., 1993, 90, 8967-8971.
9. Lovenberg, T.W.; Liaw, C.W.; Grigoriadis, D.E.; Clevenger, W.; Chalmers, D.T.; De Souza, E.B.; Oltersdorf, T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U.S.A., 1995, 92, 836-840.
10. Perrin, M.H.; Vale, W.W. Corticotropin releasing factor receptors and their ligand family. Ann. N.Y. Acad. Sci., 1999, 885, 312-328.
11. Wu, S.V.; Yuan, P.Q.; Lai, J.; Wong, K.; Chen, M.C.; Ohning, G. V.; Taché, Y. Activation of Type 1 CRH receptor isoforms induces serotonin release from human carcinoid BON-1N cells: an enterochromaffin cell model. Endocrinology, 2011, 152, 126-137.
12. Wu, S.V.; Yuan P-Q; Wang L; Peng YL; Chen C-Y; Taché Y Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus. Endocrinology, 2007, 148, 1675-1687.
13. Zmijewski, M.A.; Slominski, A.T. Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim. Pol., 2010, 57, 1-13.
14. Hauger, R.L.; Grigoriadis, D.E.; Dallman, M.F.; Plotsky, P.M.; Vale, W.W.; Dautzenberg, F.M. International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands. Pharmacol. Rev., 2003, 55, 21-26.
15. Rivier, C.L.; Grigoriadis, D.E.; Rivier, J.E. Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. Endocrinology, 2003, 144, 2396-2403.
16. Rivier, J.E.; Rivier, C.L. Corticotropin-releasing factor peptide antagonists: design, characterization and potential clinical relevance. Front. Neuroendocrinol., 2014, 35, 161-170.
17. Zorrilla, E.P.; Koob, G.F. Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov. Today, 2010, 15, 371-383.
18. Turnbull, A.V.; Rivier, C. Corticotropin-releasing factor (CRF) and endocrine response to stress: CRF receptors, binding protein, and related peptides. Proc. Soc. Exp. Biol. Med., 1997, 215, 1-10.
19. Bittencourt, J.C.; Vaughan, J.; Arias, C.; Rissman, R.A.; Vale, W. W.; Sawchenko, P.E. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J. Comp. Neurol., 1999, 415, 285-312.
20. Bittencourt, J.C.; Sawchenko, P.E. Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system. J. Neurosci., 2000, 20, 1142-1156.
21. Wang, L.; Goebel-Stengel, M.; Stengel, A.; Wu, S.V.; Ohning, G.; Taché, Y. Comparison of CRF-immunoreactive neurons distribution in mouse and rat brains and selective induction of Fos in rat hypothalamic CRF neurons by abdominal surgery. Brain Res., 2011, 1415, 34-46.
22. Bale, T.L.; Vale, W.W. CRF and CRF receptor: Role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol., 2004, 44, 525-557.
23. Habib, K.E.; Weld, K.P.; Rice, K.C.; Pushkas, J.; Champoux, M.; Listwak, S.; Webster, E.L.; Atkinson, A.J.; Schulkin, J.; Contoreggi, C.; Chrousos, G.P.; McCann, S.M.; Suomi, S.J.; Higley, J.D.; Gold, P.W. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc. Natl. Acad. Sci. USA, 2000, 97, 6079-6084.
24. Stengel, A.; Taché, Y. Corticotropin-releasing factor signaling and visceral response to stress. Exp. Biol. Med. (Maywood.) 2010, 235, 1168-1178.
25. Taché, Y.; Bonaz, B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J. Clin. Invest., 2007, 117, 33-40.
26. Usui, D.; Yamaguchi-Shima, N.; Okada, S.; Shimizu T.; Wakigu-chi, H.; Yokotani, K. Selective activation of the sympathetic ganglia by centrally administered corticotropin-releasing factor in rats. Auton Neurosci. 2009, 146,111-114.
27. Larauche, M.; Kiank, C.; Taché, Y. Corticotropin releasing factor signaling in colon and ileum: Regulation by stress and pathophysiological implications. J. Physiol Pharmacol., 2009, 60 (Suppl) 7, 33-46.
28. Yuan, P.Q.; Wu, S.V.; Wang, L.; Taché, Y. Corticotropin releasing factor in the rat colon: expression, localization and upregulation by endotoxin. Peptides., 2010, 31, 322-331.
29. Yuan, P.Q.; Wu, S.V.; Elliott, J.; Anton, P.A.; Chatzaki, E.; Million, M.; Taché, Y. Expression of corticotropin releasing factor receptor type 1 (CRF(1)) in the human gastrointestinal tract and upregulation in the colonic mucosa in patients with ulcerative colitis. Peptides, 2012, 38, 62-69.
30. Wallon, C.; Persborn, M.; Jonsson, M.; Wang, A.; Phan, V.; Lampinen, M.; Vicario, M.; Santos, J.; Sherman, P.M.; Carlson, M.; Ericson, A.C.; McKay, D.M.; Soderholm, J.D. Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis. Gastroenterology, 2011, 140, 1597-1607.
31. Adao, R.; Santos-Ribeiro, D.; Rademaker, M.T.; Leite-Moreira, A. F.; Bras-Silva, C. Urocortin 2 in cardiovascular health and disease. Drug Discov. Today, 2015, 20, 906-914.
32. Kiank, C.; Taché, Y.; Larauche, M. Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors. Brain Behav. Immun., 2010, 24, 41-48.
33. Taché, Y.; Perdue, M.H. Role of peripheral CRF signaling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol. Mot., 2004, 16(Suppl),1, 1-6.
34. Walczewska, J.; Dzieza-Grudnik, A.; Siga, O.; Grodzicki, T. The role of urocortins in the cardiovascular system. J. Physiol. Pharmacol., 2014, 65, 753-766.
35. Zorrilla, E.P.; Logrip, M.L.; Koob, G.F. Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol., 2014, 35, 234-244.
36. Taché, Y.; Brunnhuber, S. From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases. Ann. N. Y. Acad. Sci., 2008, 1148, 29-41.
37. Gravanis, A.; Margioris, A.N. The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications. Curr. Med. Chem., 2005, 12, 1503-1512.
38. Holsboer, F.; Ising, M. Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists. Eur. J. Pharmacol., 2008, 583, 350-357.
39. Taché, Y.; Million, M. Role of corticotropin-releasing factor signaling in stress-related alterations of colonic motility and hyperalgesia. J. Neurogastroenterol. Motil., 2015, 21, 8-24.
40. Taché, Y.; Goto, Y.; Gunion, M.W.; Vale, W.; River, J.; Brown, M. Inhibition of gastric acid secretion in rats by intracerebral injection of corticotropin-releasing factor. Science, 1983, 222, 935-937.
41. Druge, G.; Raedler, A.; Heiner, G.; Lenz, J. Pathways mediating CRF-induced inhibition of gastric acid secretion in rats. Am. J. Physiol., 1989, 256, G214-G219.
42. Brown, M.R.; Fisher, L.A.; Spiess, J.; Rivier, J.; Rivier, C.; Vale, W. Comparison of the biological actions of corticotropin-releasing factor and sauvagine. Regul. Pept., 1982, 4, 107-114.
43. Lenz, H.J.; Forquignon, I.; Druge, G.; Greten, H. Effects of neuropeptides on gastric acid and duodenal bicarbonate secretions in freely moving rats. Regul. Pept., 1989, 24, 293-300.
44. Gué, M.; Yoneda, M.; Mönnikes, H.; Junien, J.-L.; Taché, Y. Central neuropeptide Y and sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats. Br. J. Pharmacol., 1992, 107, 642-647.
45. Guglietta, A.; Nardi, R.V.; Lazarus, L.H. Indomethacin (i.c.v.) reverses the inhibitory action of peptides on gastric secretion. Eur. J. Immunol., 1989, 170, 87-90.
46. Lenz, H.J.; Raedler, A.; Greten, H.; Brown, M.R. CRF initiates biological actions within the brain that are observed in response to stress. Am. J. Physiol., 1987, 252, R34-R39.
47. Lenz, H. J.; Hester, S. E.; Brown, M. R. Corticotropin-releasing factor mechanisms to inhibit gastric acid secretion in conscious dogs. J. Clin. Invest., 1985, 75, 889-895.
48. Taché, Y.; Goto, Y.; Gunion, M.; Rivier, J.; Debas, H. Inhibition of gastric acid secretion in rats and in dogs by corticotropin-releasing factor. Gastroenterology, 1984, 86, 281-286.
49. Yakabi, K.; Noguchi, M.; Ohno, S.; Ro, S.; Onouchi, T.; Ochiai, M.; Takabayashi, H.; Takayama, K.; Harada, Y.; Sadakane, C.; Hattori, T. Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors. Am. J. Physiol., 2011, 301, E72-E82.
50. Gunion, M.W.; Taché, Y. Intrahypothalamic microinfusion of corticotropin-releasing factor inhibits gastric acid secretion but increases secretion volume in rats. Brain Res., 1987, 411, 156-161.
51. Gunion, M.W.; Kauffman, G.L.; Taché, Y. Intrahypothalamic microinfusion of corticotropin-releasing factor elevates gastric bicarbonate secretion and protects against cold-stress ulceration in rats. Am. J. Physiol., 1990, 258, G152-G157.
52. Mönnikes, H.; Tebbe, J.; Bauer, C.; Lauer, G.; Arnold, R. Microinfusion of corticotropin-releasing factor into the locus coeruleus/subcoeruleus nuclei inhibits gastric acid secretion via spinal pathways in the rat. Brain Res., 1996,728,157-165.
53. Kosoyan, H.P.; Wei, J.Y.; Taché, Y. Intracisternal sauvagine is more potent than corticotropin-releasing factor to decrease gastric vagal efferent activity in rats. Peptides 1999, 20, 851-858.
54. Lenz, H.J.; Raedler, A.; Greten, H.; Vale, W.W.; Rivier, J.E. Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor. Gastroenterology, 1988, 95, 1510-1517.
55. Taché, Y. The parasympathetic nervous system in the pathophysiology of the gastrointestinal tract. In Handbook of autonomic nervous system in health and disease, Bolis CL., Licinio, J., Govoni, S., Eds.; Dekker Inc: New York, 2002, pp 463-503.
56. Lenz, H.J.; Klapdor, R.; Hester, S.E.; Webb, V.J.; Galyean, R.F.; Rivier, J.E.; Brown, M.R. Inhibition of gastric acid secretion by brain peptides in the dog. Role of the autonomic nervous system and gastrin. Gastroenterology, 1986, 91, 905-912.
57. Beaumont, W. In Experiments and Observations on the Gastric Juice and the Physiology of Digestion, Osler, W., Ed.; Dover Publications Inc.: New York, 1833, pp. 1-280.
58. Cannon, W.B. Bodily changes in pain, hunger, fear and rage; Branford, CT: Boston, 1953. pp. 1-404.
59. Stephens, R.L.; Yang, H.; Rivier, J.; Taché, Y. Intracisternal injection of CRF antagonist blocks surgical stress-induced inhibition of gastric secretion in the rat. Peptides, 1988, 9, 1067-1070.
60. Mondal, M.S.; Date, Y.; Murakami, N.; Toshinai, K.; Shimbara, T.; Kangawa, K.; Nakazato, M. Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system. Am. J. Physiol., 2003, 284, G963-G969.
61. Okumura, T.; Yamada, H.; Motomura, W.; Kohgo, Y. Cocaine-amphetamine-regulated transcript (CART) acts in the central nervous system to inhibit gastric acid secretion via brain corticotropin-releasing factor system. Endocrinology, 2000, 141, 2854-2860.
62. Tebbe, J.J.; Mronga S.; Schäfer, M.K.; Rüter J.; Kobelt, P.; Mönnikes, H. Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors. Am. J. Physiol., 2003,285, G1075-1083.
63. Williams, C.L.; Peterson, J.M.; Villar, R.G.; Burks, T.F. Corticotropin-releasing factor directly mediates colonic responses to stress. Am. J. Physiol., 1987, 253, G582-G586.
64. Taché, Y.; Maeda-Hagiwara, M.; Turkelson, C.M. Central nervous system action of corticotropin-releasing factor to inhibit gastric emptying in rats. Am. J. Physiol., 1987, 253, G241-G245.
65. Lenz, H.J.; Burlage, M.; Raedler, A.; Greten, H. Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat. Gastroenterology, 1988, 94, 598-602.
66. Sheldon, R.J.; Qi, J.A.; Porreca, F.; Fisher, L.A. Gastrointestinal motor effects of corticotropin-releasing factor in mice. Regul. Pept., 1990, 28, 137-151.
67. Riviere, P.J.; Pascaud, X.; Chevalier, E.; Junien, J.L. Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents. J. Pharmacol. Exp. Ther., 1994, 270, 846-850.
68. Smedh, U.; Uvnäs-Moberg, K.; Grill, H.J.; Kaplan, J.M. Fourth ventricle injection of corticotropin-releasing factor and gastric emptying of glucose during gastric fill. Am. J. Physiol., 1995, 269, G1000-G1003.
69. Coskun, T.; Bozkurt, A.; Alican, I.; Özkutlu, U.; Kurtel, H.; Yegen, Ç. Pathways mediating CRF-induced inhibition of gastric emptying in rats. Regul. Pept., 1997, 69, 113-120.
70. Lee, C.; Sarna, S.K. Central regulation of gastric emptying of solid nutrient meals by corticotropin releasing factor. Neurogastroenterol. Mot., 1997, 9, 221-229.
71. Martinez, V.; Wang, L.; Rivier, J.; Grigoriadis, D.; Taché, Y. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice. J. Physiol., 2004, 556.1, 221-234.
72. Nakade, Y.; Tsuchida, D.; Fukuda, H.; Iwa, M.; Pappas, T.N.; Takahashi, T. Restraint stress delays solid gastric emptying via a central CRF and peripheral sympathetic neuron in rats. Am. J. Physiol., 2005, 288, R427-R432.
73. Czimmer, J.; Million, M.; Taché, Y. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats. Am. J. Physiol., 2006, 290, G511-G518.
74. Ushikai, M.; Asakawa, A.; Sakoguchi, T.; Tanaka, C.; Inui, A. Centrally administered urocortin 3 inhibits food intake and gastric emptying in mice. Endocrine, 2011, 39, 113-117.
75. Ruckebusch, Y.; Malbert, C. H. Stimulation and inhibition of food intake in sheep by centrally-administered hypothalamic releasing factors. Life Sci., 1986, 38, 929-934.
76. Buéno, L.; Fargeas, M.J.; Gue, M.; Peeters, T.L.; Bormans, V.; Fioramonti, J. Effects of corticotropin-releasing factor on plasma motilin and somatostatin levels and gastrointestinal motility in dogs. Gastroenterology, 1986, 91, 884-889.
77. Chen, C.Y.; Million, M.; Adelson, D.W.; Martinez, V.; Rivier, J.; Taché, Y. Intracisternal urocortin inhibits vagally stimulated gastric motility in rats: role of CRF(2). Br. J. Pharmacol., 2002, 136, 237-247.
78. Nakade, Y.; Tsuchida, D.; Fukuda, H.; Iwa, M.; Pappas, T.N.; Takahashi, T. Restraint stress augments postprandial gastric contractions but impairs antropyloric coordination in conscious rats. Am. J. Physiol., 2006, 290, R616-R624.
79. Ataka, K.; Nagaishi, K.; Asakawa, A.; Inui, A.; Fujimiya, M. Alteration of antral and proximal colonic motility induced by chronic psychological stress involves central urocortin 3 and vasopressin in rats. Am. J. Physiol., 2012, 303, G519-G528.
80. Browning, K.N.; Babic, T.; Toti, L.; Holmes, G.M.; Coleman, F. H.; Travagli, R.A. Plasticity in the brainstem vagal circuits controlling gastric motor function triggered by corticotropin releasing factor. J. Physiol., 2014, 592, 4591-4605.
81. Kihara, N.; Fujimura, M.; Yamamoto, I.; Itoh, E.; Inui, A.; Fujimiya, M. Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats. Am. J. Physiol., 2001, 280, G406-G419.
82. Garrick, T.; Veiseh, A.; Sierra, A.; Weiner, H.; Taché, Y. Corticotropin-releasing factor acts centrally to suppress stimulated gastric contractility in the rat. Regul. Pept., 1988, 21, 173-181.
83. Heymann-Monnikes, I.; Taché, Y.; Trauner, M.; Weiner, H.; Garrick, T. CRF microinjected into the dorsal vagal complex inhibits TRH analog- and kainic acid-stimulated gastric contractility in rats. Brain. Res., 1991, 554, 139-144.
84. Buéno, L.; Fioramonti, J. Effects of corticotropin-releasing factor, corticotropin and cortisol on gastrointestinal motility in dogs. Peptides, 1986, 7, 73-77.
85. Gué, M.; Fioramonti, J.; Frexinos, J.; Alvinerie, M.; Buéno, L. Influence of acoustic stress by noise on gastrointestinal motility in dogs. Dig. Dis. Sci., 1987, 32, 1411-1417.
86. 2 receptors. Am. J. Physiol., 1998, 274, G965-G970.
87. Martinez, V.; Rivier, J.; Wang, L.; Taché, Y. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. J. Pharmacol. Exp. Ther., 1997, 280, 754-760.
88. Taché, Y.; Barquist, E.; Stephens, R.L.; Rivier, J. Abdominal surgery- and trephination-induced delay in gastric emptying is prevented by intracisternal injection of CRF antagonist in the rat. J. Gastrointest. Motil., 1991, 3, 19-25.
89. Sütó, G.; Király, A.; Taché, Y. Interleukin-1b inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor. Gastroenterology 1994, 106, 1568-1575.
90. Barquist, E.; Bonaz, B.; Martinez, V.; Rivier, J.; Zinner, M.J.; Taché, Y. Neuronal pathways involved in abdominal surgery-induced gastric ileus in rats. Am. J. Physiol., 1996, 270, R888-R894.
91. Martinez, V.; Taché, Y. Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats. Brain Res., 2001, 893, 29-35.
92. Mönnikes, H.; Schmidt, B.G.; Raybould, H.E.; Taché, Y. CRF in the paraventricular nucleus mediates gastric and colonic motor response to restraint stress. Am. J. Physiol., 1992, 262, G137-G143.
93. Mönnikes, H.; Schmidt, B.G.; Tebbe, J.; Bauer, C.; Taché, Y. Microinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus stimulates colonic motor function in rats. Brain Res., 1994, 644, 101-108.
94. Smedh, U.; Moran, T.H. The dorsal vagal complex as a site for cocaine- and amphetamine-regulated transcript peptide to suppress gastric emptying. Am. J. Physiol. Regul., 2006, 291, R124-R130.
95. Lewis, M.W.; Hermann, G.E.; Rogers, R.C.; Travagli, R.A. In vitro and in vivo analysis of the effects of corticotropin releasing factor on rat dorsal vagal complex. J. Physiol., 2002, 543, 135-146.
96. Swanson, L.W.; Sawchenko, P.E. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology, 1980, 31, 410-417.
97. Broccardo, M.; Improta, G. Pituitary-adrenal and vagus modulation of sauvagine- and CRF-induced inhibition of gastric emptying in rats. Eur. J. Pharmacol., 1990, 182, 357-362.
98. Kang, Y.M.; Zhang, A.Q.; Zhao, X.F.; Cardinale, J.P.; Elks, C.; Cao, X.M.; Zhang, Z.W.; Francis, J. Paraventricular nucleus corticotrophin releasing hormone contributes to sympathoexcitation via interaction with neurotransmitters in heart failure. Basic Res. Cardiol., 2011, 106, 473-483.
99. Smedh, U.; Kaplan, J.M.; Uvnas-Moberg, K. Corticotropin-releasing factor-induced suppression of gastric emptying in the rat is blocked by cyclo 7-aminoheptanoyl-phe-D-TRP-LYS-THR[BZL], an in vivo somatostatin antagonist. Neurosci. Lett., 1999, 260, 41-44.
100. Rivier, J.; Gulyas, J.; Corrigan, A.; Martinez, V.; Craig, A.G.; Taché, Y.; Vale, W.; Rivier, C. Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat. J. Med. Chem., 1998, 41, 5012-5019.
101. Suto, G.; Kiraly, A.; Plourde, V.; Taché, Y. Intravenous interleukin-1-beta-induced inhibition of gastric emptying: involvement of central corticotropin-releasing factor and prostaglandin pathways in rats. Digestion, 1996, 57, 135-140.
102. Taché, Y.; Martinez, V.; Million, M.; Wang, L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am. J. Physiol., 2001, 280, G173-G177.
103. Bonaz, B.; Plourde, V.; Taché, Y. Abdominal surgery induces Fos immunoreactivity in the rat brain. J. Comp. Neurol., 1994, 349, 212-222.
104. Harbuz, M.S.; Lightman, S.L. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J. Endocrinol., 1989, 122, 705-711.
105. Rivest, S.; Rivier, C. Stress and interleukin-1 beta-induced activation of c-fos, NGFI-B and CRF gene expression in the hypothalamic PVN: comparison between Sprague- Dawley, Fisher-344 and Lewis rats. J. Neuroendocrinol., 1994, 6, 101-117.
106. Gourcerol, G.; Gallas, S.; Mounien, L.; Leblanc, I.; Bizet, P.; Boutelet, I.; Leroi, A.M.; Ducrotte, P.; Vaudry, H.; Jegou, S. Gastric electrical stimulation modulates hypothalamic corticotropin-releasing factor-producing neurons during postoperative ileus in rat. Neuroscience, 2007, 148, 775-781.
107. Rivest, S. Molecular mechanisms and neural pathways mediating the influence of interleukin-1 on the activity of neuroendocrine CRF motoneurons in the rat. Int. J. Dev. Neurosci., 1995, 13, 135-146.
108. Rivier, C. Influence of immune signals on the hypothalamic-pituitary axis of the rodent. Front. Neuroendocrinol., 1995, 16, 151-182.
109. Tanaka, Y.; Makino, S.; Noguchi, T.; Tamura, K.; Kaneda, T.; Hashimoto, K. Effect of stress and adrenalectomy on urocortin II mRNA expression in the hypothalamic paraventricular nucleus of the rat. Neuroendocrinology, 2003, 78, 1-11.
110. Korosi, A.; Schotanus, S.; Olivier, B.; Roubos, E.W.; Kozicz, T. Chronic ether stress-induced response of urocortin 1 neurons in the Edinger-Westphal nucleus in the mouse. Brain Res., 2005, 1046, 172-179.
111. Luckey, A.; Wang, L.; Jamieson, P.M.; Basa, N.R.; Million, M.; Czimmer, J.; Vale, W.; Taché, Y. Corticotropin-releasing factor receptor 1-deficient mice do not develop postoperative gastric ileus. Gastroenterology, 2003, 125, 654-659.
112. Ulrich-Lai, Y.M.; Herman, J.P. Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci., 2009, 10, 397-409.
113. Smedh, U.; Moran, T.H. Peptides that regulate food intake: separable mechanisms for dorsal hindbrain CART peptide to inhibit gastric emptying and food intake. Am. J. Physiol., 2003, 284, R1418-R1426.
114. Broccardo, M.; Scaccianoce, S.; Del, B.P.; Agostini, S.; Petrella, C.; Improta, G. Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors. Neurogastroenterol. Motil., 2005, 17, 871-877.
115. Nakade, Y.; Tsukamoto, K.; Pappas, T.N.; Takahashi, T. Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats. Brain Res., 2006, 1111, 117-121.
116. Chen, C.Y.; Inui, A.; Asakawa, A.; Fujino, K.; Kato, I.; Chen, C. C.; Ueno, N.; Fujimiya, M. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology, 2005, 129, 8-25.
117. Martinez, V.; Cuttitta, F.; Taché, Y. Central action of adrenomedullin to inhibit gastric emptying in rats. Endocrinology, 1997, 138, 3749-3755.
118. Stengel, A.; Goebel, M.; Wang, L.; Rivier, J.; Kobelt, P.; Monnikes, H.; Lambrecht, N.W.; Taché, Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology, 2009, 150, 4911-4919.
119. Lenz, H.J.; Forquignon, I.; Druge, G.; Friemel, E.; Rivier, J.E.; Raedler, A.; Greten, H. Central nervous system effects of hypothalamic peptides on gastric acid and proximal duodenal bicarbonate secretions in rats. Gastroenterology, 1987, 92, 1501 Abstr.
120. Lenz, H.J. Regulation of duodenal bicarbonate secretion during stress by corticotropin-releasing factor and b-endorphin. Proc. Natl. Acad. Sci. U. S. A., 1989, 86, 1417-1420.
121. Flemstrom, G.; Jedstedt, G. Stimulation of duodenal mucosal bicarbonate secretion in the rat by brain peptides. Gastroenterology, 1989, 97, 412-420.
122. Lenz, H.J. Regulation of small intestinal and pancreaticobiliary functions by CRF. Ann. N. Y. Acad. Sci., 1993, 697, 254-259.
123. Brown, M.R.; Fisher, L.A.; Spiess, J.; Rivier, C.; Rivier, J.; Vale, W. Corticotropin-releasing factor: Action on the sympathetic nervous system and metabolism. Endocrinology, 1982, 111, 928-931.
124. Yin, Y.; Dong, L.; Yin, D. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism. J. Gastroenterol. Hepatol., 2008, 23, e79-e87.
125. Jiménez, M.; Buéno, L. Inhibitory effects of neuropeptide Y (NPY) on CRF and stress-induced cecal motor response in rats. Life Sci., 1990, 47, 205-211.
126. Bonaz, B.; Taché, Y. Water-avoidance stress-induced c-fos expression in the rat brain and stimulation of fecal output: role of corticotropin-releasing factor. Brain Res., 1994, 641, 21-28.
127. Miyata, K.; Ito, H.; Fukudo, S. Involvement of the 5-HT3 receptor in CRH-induce defecation in rats. Am. J. Physiol., 1998, 274, G827-G831.
128. Gué, M.; Tekamp, A.; Tabis, N.; Junien, J.L.; Buéno, L. Cholecystokinin blockade of emotional stress- and CRF-induced colonic motor alterations in rats: role of the amygdala. Brain Res., 1994, 658, 232-238.
129. Gué, M.; Junien, J.L.; Buéno, L. Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor. Gastroenterology, 1991, 100, 964-970.
130. 1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats. Brain Res., 2003, 985, 32-42.
131. Ataka, K.; Kuge, T.; Fujino, K.; Takahashi, T.; Fujimiya, M. Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats. Auton. Neurosci., 2007, 133, 136-145.
132. Million, M.; Zhao, J.F.; Luckey, A.; Czimmer, J.; Maynard, G.D.; Kehne, J.; Hoffman, D.C.; Taché, Y. The newly developed CRF1-receptor antagonists, NGD 98-2 and NGD 9002, suppress acute stress-induced stimulation of colonic motor function and visceral hypersensitivity in rats. PLoS. One., 2013, 8, e73749.
133. Castagliuolo, I.; Lamont, J.T.; Qiu, B.; Fleming, S.M.; Bhaskar, K. R.; Nikulasson, S.T.; Kornetsky, C.; Pothoulakis, C. Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am. J. Physiol., 1996, 271, G884-G892.
134. Mönnikes, H.; Raybould, H.E.; Schmidt, B.; Taché, Y. CRF in the paraventricular nucleus of the hypothalamus stimulates colonic motor activity in fasted rats. Peptides, 1993, 14, 743-747.
135. Mönnikes, H.; Schmidt, B.G.; Taché, Y. Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor. Gastroenterology, 1993, 104, 716-723.
136. Mönnikes, H.; Heymann-Monnikes, I.; Taché, Y. CRF in the paraventricular nucleus of the hypothalamus induces dose-related behavioral profile in rats. Brain Res., 1992, 574, 70-76.
137. Koob, G.F.; Heinrichs, S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res., 1999, 848, 141-152.
138. Itoi, K.; Sugimoto, N. The brainstem noradrenergic systems in stress, anxiety and depression. J. Neuroendocrinol., 2010, 22, 355-361.
139. Allain, P.; Lechat, P. Action of some psychotropic drugs on emotional defecation in mice. Therapie, 1970, 25, 655-662.
140. Rouzade-Dominguez, M.L.; Pernar, L.; Beck, S.; Valentino, R.J. Convergent responses of Barrington's nucleus neurons to pelvic visceral stimuli in the rat: A juxtacellular labelling study. Eur. J. Neurosci., 2003, 18, 3325-3334.
141. Sawchenko, P.E.; Swanson, L.W. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or the spinal cord in the rat. J. Comp. Neurol., 1982, 205, 260-272.
142. Million, M.; Wang, L.; Martinez, V.; Taché, Y. Differential Fos expression in the paraventricular nucleus of the hypothalamus, sacral parasympathetic nucleus and colonic motor response to water avoidance stress in Fischer and Lewis rats. Brain Res., 2000, 877, 345-353.
143. Nakade, Y.; Fukuda, H.; Iwa, M.; Tsukamoto, K.; Yanagi, H.; Yamamura, T.; Mantyh, C.; Pappas, T.N.; Takahashi, T. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats. Am. J. Physiol., 2007, 292, G1037-G1044.
144. Tebbe, J.J.; Pasat, I.R.; Mönnikes, H.; Ritter, M.; Kobelt, P.; Schafer, M.K. Excitatory stimulation of neurons in the arcuate nucleus intitiates central CRF-dependent stimulation of colonic propulsion in rats. Brain Res., 2005, 1036, 130-138.
145. Haga, K.; Asano, K.; Fukuda, T.; Kobayakawa, T. The function of 5-HT3 receptors on colonic transit in rats. Obesity Res., 1995, 3, 801S-810S.
146. Okano, S.; Nagaya, H.; Ikeura, Y.; Natsugari, H.; Inatomi, N. Effects of TAK-637, a novel neurokinin-1 receptor antagonist, on colonic function in vivo. J. Pharmacol. Exp. Ther. 2001, 298, 559-564.
147. 1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br. J. Pharmacol., 2004, 141, 1321-1330.
148. Chen, C.Y.; Doong, M.L.; Li, C.P.; Liaw, W.J.; Lee, H.F.; Chang, F.Y.; Lin, H.C.; Lee, S.D. A novel simultaneous measurement method to assess the influence of intracerebroventricular obestatin on colonic motility and secretion in conscious rats. Peptides, 2010, 31, 1113-1117.
149. Buéno, L.; Gue, M.; Delrio, C. CNS vasopressin mediates emotional stress and CRH-induced colonic motor alterations in rats. Am. J. Physiol., 1992, 262, G427-G431.
150. Hirata, T.; Keto, Y.; Nakata, M.; Takeuchi, A.; Funatsu, T.; Akuzawa, S.; Sasamata, M.; Miyata, K. Effects of serotonin 5-HT(3)receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats. Eur. J. Pharmacol., 2008, 587, 281-284.
151. Funatsu, T.; Takeuchi, A.; Hirata, T.; Keto, Y.; Akuzawa, S.; Sasamata, M. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats. Eur. J. Pharmacol., 2007, 573, 190-195.
152. Seymour, P.A.; Schmidt, A.W.; Schulz, D.W. The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review. CNS. Drug Rev., 2003, 9, 57-96.
153. Gabry, K.E.; Chrousos, G.P.; Rice, K.C.; Mostafa, R.M.; Sternberg, E.; Negrao, A.B.; Webster, E.L.; McCann, S.M.; Gold, P.W. Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs. Mol. Psychiatry., 2002, 7, 474-483.
154. Maillot, C.; Million, M.; Wei, J.Y.; Gauthier, A.; Taché, Y. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats. Gastroenterology, 2000, 119, 1569-1579.
155. Saito, K.; Kasai, T.; Nagura, Y.; Ito, H.; Kanazawa, M.; Fukudo, S. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats. Gastroenterology, 2005, 129, 1533-1543.
156. Yoshimoto, S.; Cerjak, D.; Babygirija, R.; Bulbul, M.; Ludwig, K.; Takahashi, T. Hypothalamic circuit regulating colonic transit following chronic stress in rats. Stress, 2012, 15, 227-236.
157. Funada, M.; Hara, C.; Wada, K. Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system. Eur. J. Pharmacol., 2001, 430, 277-281.
158. Bale, T.L.; Picetti, R.; Contarino, A.; Koob, G.F.; Vale, W.W.; Lee, K.F. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J. Neurosci., 2002, 22, 193-199.
159. Million, M.; Wang, L.; Stenzel-Poore, M.P.; Coste, SC.; Yuan, P. Q.; Lamy, C.; Rivier, J.; Buffington, T.; Taché, Y. Enhanced pelvic responses to stressors in female CRF-overexpressing mice. Am. J. Physiol., 2006, 292, R1429-R1438.
160. Bonaz, B.; Rivest, S. Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain. Am. J. Physiol., 1998, 275, R1438-R1449.
161. Reyes, B.A.; Bangasser, D.A.; Valentino, R.J.; Van Bockstaele, E. J. Using high resolution imaging to determine trafficking of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Life Sci., 2014, 112, 2-9.
162. Taché, Y. Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia. Neurogastroenterol. Motil., 2015, 27, 1-6.
163. Sternberg, E.M.; Glowa, J.R.; Smith, M.A.; Calogero, A.E.; Listwak, S.J.; Aksentijevich, S.; Chrousos, G.P.; Wilder, R.L.; Gold, P.W. Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res., 1992, 570, 54-60.
164. Tebbe, J.J.; Mronga, S.; Tebbe, C.G.; Ortmann, E.; Arnold, R.; Schafer, M. K. Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1- and corticotrophin-releasing factor 1 receptor activation. J. Neuroendocrinol., 2005, 17, 570-576.
165. Mönnikes, H.; Tebbe, J.; Bauer, C.; Grote, C.; Arnold, R. Neuropeptide Y in the paraventricular nucleus of the hypothalamus stimulates colonic transit by peripheral cholinergic and central CRF pathways. Neurogastroenterol. Motil., 2000, 12, 343-352.
166. Tebbe, J.J.; Ortmann, E.; Schumacher, K.; Monnikes, H.; Kobelt, P.; Arnold, R.; Schafer, M.K. Cocaine- and amphetamine-regulated transcript stimulates colonic motility via central CRF receptor activation and peripheral cholinergic pathways in fed, conscious rats. Neurogastroenterol. Motil., 2004, 16, 489-496.
167. Junien, J.L.; Gué, M.; Buéno, L. Neuropeptide Y and sigma ligand (JO 1784) act through a Gi protein to block the psychological stress and corticotropin-releasing factor-induced colonic motor activation in rats. Neuropharmacology, 1991, 30, 1119-1124.
168. Nakade, Y.; Tsukamoto, K.; Iwa, M.; Pappas, T.N.; Takahashi, T. Glucagon like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats. Auton. Neurosci., 2007, 131, 50-56.
169. Spiegel, B.M.; Bolus, R.; Harris, L.A.; Lucak, S.; Chey, W.D.; Sayuk, G.; Esrailian, E.; Lembo, A.; Karsan, H.; Tillisch, K.; Talley, J.; Chang, L. Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice. Aliment. Pharmacol. Ther., 2010, 32, 1192-1202.
170. Chang, L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology, 2011, 140, 761-765.
171. Qin, H.Y.; Cheng, C.W.; Tang, X.D.; Bian, Z.X. Impact of psychological stress on irritable bowel syndrome. World J. Gastroenterol., 2014, 20, 14126-14131.
172. Grinsvall, C.; Tornblom, H.; Tack, J.; Van, O.L.; Simren, M. Psychological factors selectively upregulate rectal pain perception in hypersensitive patients with irritable bowel syndrome. Neurogastroenterol. Motil., 2015, 27, 1772-1782.
173. Larauche, M.; Mulak, A.; Taché, Y. Stress-related alterations of visceral sensation: animal models for irritable bowel syndrome study. J. Neurogastroenterol. Motil., 2011, 17, 213-234.
174. Greenwood-Van, M.B.; Prusator, D.K.; Johnson, A.C. Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges. Am. J. Physiol., 2015, 308, G885-G903.
175. Gué, M.; Del Rio-Lacheze, C.; Eutamene, H.; Theodorou, V.; Fioramonti, J.; Buéno, L. Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol. Motil., 1997, 9, 271-279.
176. Greenwood-Van Meerveld, B.; Johnson, A.C.; Cochrane, S.; Schulkin, J.; Myers, D.A. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol. Motil., 2005, 17, 415-422.
177. Schwetz, I.; Bradesi, S.; McRoberts, J.A.; Sablad, M.; Miller, J.C.; Zhou, H.; Ohning, G.; Mayer, E.A. Delayed stress-induced colonic hypoersensitivity in male Wistar rats: role of neurokinin-1 and corticotropin releasing factor-1 receptors. Am. J. Physiol., 2004, 286, G683-G691.
178. Schwetz, I.; McRoberts, J.A.; Coutinho, S.V.; Bradesi, S.; Gale, G.; Fanselow, M.; Million, M.; Ohning, G.; Taché, Y.; Plotsky, P.M.; Mayer, E.A. Corticotropin-releasing factor receptor 1 mediates acute and delayed stress-induced visceral hyperalgesia in maternally separated Long-Evans rats. Am. J. Physiol., 2005, 289, G704-G712.
179. Larauche, M.; Bradesi, S.; Million, M.; McLean, P.; Taché, Y.; Mayer, E.A.; McRoberts, J.A. Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats. Am. J. Physiol., 2008, 294, G1033-G1040.
180. Saito-Nakaya, K.; Hasegawa, R.; Nagura, Y.; Ito, H.; Fukudo, S. Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension. Neurogastroenterol. Motil., 2008, 20, 1147-1156.
181. Jia, F.Y.; Li, X.L.; Li, T.N.; Wu, J.; Xie, B.Y.; Lin, L. Role of nesfatin-1 in a rat model of visceral hypersensitivity. World J. Gastroenterol., 2013, 19, 3487-3493.
182. Million, M.; Maillot, C.; Adelson, D.W.; Nozu, T.; Gauthier A; Rivier, C.; Chrousos, G.P.; Bayati, A.; Mattsson, H.; Taché, Y. Peripheral injection of sauvagine prevents repeated colorectal distention-induced visceral pain in female rats. Peptides, 2005, 26, 1188-1195.
183. Buckley, M.M.; O'Halloran, K.D.; Rae, M.G.; Dinan, T.G.; o'malley, D. Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome. J. Physiol., 2014, 592(23), 5235-5250.
184. Smith, C.; Nordstrom, E.; Sengupta, J.N.; Miranda, A. Neonatal gastric suctioning results in chronic visceral and somatic hyperalgesia: role of corticotropin releasing factor. Neurogastroenterol. Motil., 2007, 19, 692-699.
185. Trimble, N.; Johnson, A. C.; Foster, A.; Greenwood-Van Meerveld, B. Corticotropin-releasing factor receptor 1-deficient mice show decreased anxiety and colonic sensitivity. Neurogastroenterol. Motil., 2007, 19, 754-760.
186. Bradesi, S.; Martinez, V.; Lao, L.; Larsson, H.; Mayer, E. A. Involvement of vasopressin 3 receptors in chronic psychological stress-induced visceral hyperalgesia in rats. Am. J. Physiol., 2009, 296, G302-G309.
187. Johnson, A.C.; Tran, L.; Schulkin, J.; Greenwood-Van Meerveld, B. Importance of stress receptor-mediated mechanisms in the amygdala on visceral pain perception in an intrinsically anxious rat. Neurogastroenterol. Motil., 2012, 24, 479-86, e219.
188. Tran, L.; Schulkin, J.; Greenwood-Van Meerveld, B. Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain. Neuropsychopharmacology, 2014, 39, 2633-2645.
189. Su, J.; Tanaka, Y.; Muratsubaki, T.; Kano, M.; Kanazawa, M.; Fukudo, S. Injection of corticotropin-releasing hormone into the amygdala aggravates visceral nociception and induces noradrenaline release in rats. Neurogastroenterol. Motil., 2014, 27(1), 30-39.
190. Van Bockstaele, E.J.; Colago, E.E.; Valentino, R.J. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J. Neuroendocrinol., 1998, 10, 743-757.
191. Gray, T.S. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann. N. Y. Acad. Sci., 1993, 697, 53-60.
192. Bravo, J.A.; Dinan, T.G.; Cryan, J.F. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. Int. J. Neuropsychopharmacol., 2011, 14, 666-683.
193. Johnson, A.C.; Tran, L.; Greenwood-Van, M.B. Knockdown of corticotropin-releasing factor in the central amygdala reverses persistent viscerosomatic hyperalgesia. Transl. Psychiatry, 2015, 5, e517.
194. Kim, S.H.; Han, J.E.; Hwang, S.; Oh, D.H. The expression of corticotropin-releasing factor in the central nucleus of the amygdala, induced by colorectal distension, is attenuated by general anesthesia. J. Korean Med. Sci., 2010, 25, 1646-1651.
195. Tran, L.; Chaloner, A.; Sawalha, A.H.; Greenwood Van-Meerveld, B. Importance of epigenetic mechanisms in visceral pain induced by chronic water avoidance stress. Psychoneuroendocrinology 2013, 38, 898-906.
196. Ji, G.; Fu, Y.; Ruppert, K. A.; Neugebauer, V. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol. Pain, 2007, 3, 13.
197. Rouwette, T.; Klemann, K.; Gaszner, B.; Scheffer, G.J.; Roubos, E. W.; Scheenen, W.J.; Vissers, K.; Kozicz, T. Differential responses of corticotropin-releasing factor and urocortin 1 to acute pain stress in the rat brain. Neuroscience, 2011, 183, 15-24.
198. Greenwood-Van Meerveld, B.; Johnson, A.C.; Schulkin, J.; Myers, D.A. Long-term expression of corticotropin-releasing factor (CRF) in the paraventricular nucleus of the hypothalamus in response to an acute colonic inflammation. Brain Res., 2006, 1071, 91-96.
199. Nishii, H.; Nomura, M.; Aono, H.; Fujimoto, N.; Matsumoto, T. Up-regulation of galanin and corticotropin-releasing hormone mRNAs in the key hypothalamic and amygdaloid nuclei in a mouse model of visceral pain. Regul. Pept., 2007, 141, 105-112.
200. Rouwette, T.; Vanelderen, P.; Roubos, E.W.; Kozicz, T.; Vissers, K. The amygdala, a relay station for switching on and off pain. Eur. J. Pain, 2012, 16, 782-792.
201. Ji, G.; Neugebauer, V. Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala. J. Neurophysiol., 2007, 97, 3893-3904.
202. Neugebauer, V.; Li, W.; Bird, G.C.; Han, J.S. The amygdala and persistent pain. Neuroscientist., 2004, 10, 221-234.
203. Fu, Y.; Neugebauer, V. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J. Neurosci., 2008, 28, 3861-3876.
204. Ji, G.; Fu, Y.; Adwanikar, H.; Neugebauer, V. Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses. Mol. Pain, 2013, 9, 2.
205. Refojo, D.; Schweizer, M.; Kuehne, C.; Ehrenberg, S.; Thoeringer, C.; Vogl, A.M.; Dedic, N.; Schumacher, M.; von Wolff, G.; Avrabos, C.; Touma, C.; Engblom, D.; Schutz, G.; Nave, K.A.; Eder, M.; Wotjak, C.T.; Sillaber, I.; Holsboer, F.; Wurst, W.; Deussing, J. M. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science, 2011, 333, 1903-1907.
206. 1 antagonist, NBI-35965 abolished the activation of locus coeruleus by colorectal distention and intracisternal CRF in rats. Brain Res., 2004, 1056, 85-96.
207. Rouzade-Dominguez, M.L.; Curtis, A.L.; Valentino, R.J. Role of Barrington's nucleus in the activation of rat locus coeruleus neurons by colonic distension. Brain Res., 2001, 917, 206-218.
208. Lechner, S.M.; Curtis, A.L.; Brons, R.; Valentino, R.J. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res., 1997, 756, 114-124.
209. Kravets, J.L.; Reyes, B.A.; Unterwald, E.M.; Van Bockstaele, E.J. Direct targeting of peptidergic amygdalar neurons by noradrenergic afferents: linking stress-integrative circuitry. Brain Struct. Funct., 2015, 220(1), 541-58.
210. Naliboff, B.D.; Munakata, J.; Fullerton, S.; Gracely, R.H.; Kodner, A.; Harraf, F.; Mayer, E.A. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut, 1997, 41, 505-512.
211. Berridge, C.W. Noradrenergic modulation of arousal. Brain Res. Rev., 2008, 58, 1-17.
212. Kehne, J.; De Lombaert, S. Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders. Curr. Drug Target CNS. Neurol. Disord., 2002, 1, 467-493.
213. Fond, G.; Loundou, A.; Hamdani, N.; Boukouaci, W.; Dargel, A.; Oliveira, J.; Roger, M.; Tamouza, R.; Leboyer, M.; Boyer, L. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): A systematic review and meta-analysis. Eur. Arch. Psychiat. Clin. Neurosci., 2014, 264, 651-660.
214. Vicario, M.; Guilarte, M.; Alonso, C.; Yang, P.; Martinez, C.; Ramos, L.; Lobo, B.; Gonzalez, A.; Guila, M.; Pigrau, M.; Saperas, E.; Azpiroz, F.; Santos, J. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress. Brain Behav. Immun., 2010, 24, 1166-1175.
215. Vicario, M.; Alonso, C.; Guilarte, M.; Serra, J.; Martinez, C.; Gonzalez-Castro, A.M.; Lobo, B.; Antolin, M.; Andreu, A.L.; Garcia-Arumi, E.; Casellas, M.; Saperas, E.; Malagelada, J. R.; Azpiroz, F.; Santos, J. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction. Psychoneuroendocrinology, 2012, 37, 65-77.
216. Eutamene, H.; Theodorou, V.; Fioramonti, J.; Buéno, L. Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats. J. Physiol., 2003, 553, 959-966.
217. Larauche, M. Novel insights in the role of peripheral corticotropin-releasing factor and mast cells in stress-induced visceral hypersensitivity. Neurogastroenterol. Motil., 2012, 24, 201-205.
218. Chatzaki, E.; Crowe, P.D.; Wang L; Million, M.; Taché, Y.; Grigoriadis, D. CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J. Neurochem., 2004, 90, 309-316.
219. Yuan, P.Q.; Million, M.; Wu, S.V.; Rivier, J.; Taché, Y. Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol. Motil., 2007, 19, 923-936.
220. o'malley, D.; Julio-Pieper, M.; Gibney, S.M.; Gosselin, R.D.; Dinan, T.G.; Cryan, J.F. Differential stress-induced alterations of colonic corticotropin-releasing factor receptors in the Wistar Kyoto rat. Neurogastroenterol. Motil., 2010, 22, 301-311.
221. Kimura, T.; Amano, T.; Uehara, H.; Ariga, H.; Ishida, T.; Torii, A.; Tajiri, H.; Matsueda, K.; Yamato, S. Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon. Am. J. Physiol., 2007, 293, G903-G910.
222. Gourcerol, G.; Wu, S.V.; Yuan, P.Q.; Pham, H.; Miampamba, M.; Larauche, M.; Sanders, P.; Amano, T.; Mulak, A.; Im, E.; Pothoulakis, C.; Rivier, J.; Taché, Y.; Million, M. Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents. Gastroenterology, 2011, 140, 1586-1596.
223. Kawahito, Y.; Sano, H.; Kawata, M.; Yuri, K.; Mukai, S.; Yamamura, Y.; Kato, H.; Chrousos, G.P.; Wilder, R. L.; Kondo, M. Local secretion of corticotropin-releasing hormone by enterochromaffin cells in human colon. Gastroenterology, 1994, 106, 859-865.
224. O'malley, D.; Cryan, J.F.; Dinan, T.G. Crosstalk between interleukin-6 and corticotropin-releasing factor modulate submucosal plexus activity and colonic secretion. Brain Behav. Immun., 2013, 30, 115-124.
225. Sand, E.; Themner-Persson, A.; Ekblad, E. Corticotropin releasing factor-distribution in rat intestine and role in neuroprotection. Regul. Pept., 2011, 166, 68-75.
226. Takahashi, K. Distribution of urocortins and corticotropin-releasing factor receptors in the cardiovascular system. Int. J. Endocrinol., 2012, 2012, 395284.
227. O'malley, D.; Dinan, T.G.; Cryan, J.F. Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: differential effects of acute psychological and physical stressors. Peptides, 2010, 31, 662-670.
228. Yuan, P.Q.; Wu, S.V.; Pothoulakis, C.; Taché, Y. Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect. Am. J. Physiol., 2016, 310(6),G387-398.
229. Martinez, V.; Wang, L.; Rivier, J.E.; Vale, W.; Taché, Y. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J. Pharmacol. Exp. Ther., 2002, 301, 611-617.
230. Tsukamoto, K.; Nakade, Y.; Mantyh, C.; Ludwig, K.; Pappas, T. N.; Takahashi, T. Peripherally administered CRF stimulates colonic motility via central CRF receptors and vagal pathways in conscious rats. Am. J. Physiol., 2006, 290, R1537-R1541.
231. 2-mediated action on gastric transit in rats. Am. J. Physiol., 2002, 282, G34-G40.
232. 1 receptor in fecal watery excretion. Eur. J. Pharmacol., 2002, 435, 231-235.
233. Maillot, C.; Wang, L.; Million, M.; Taché, Y. Intraperitoneal corticotropin-releasing factor and urocortin induce Fos expression in brain and spinal autonomic nuclei and long lasting stimulation of colonic motility in rats. Brain Res., 2003, 974, 70-81.
234. Gourcerol, G.; Wang, L.; Adelson, D.W.; Larauche, M.; Taché, Y.; Million, M. Cholinergic giant migrating contractions in conscious mouse colon assessed by using a novel noninvasive solid-state manometry method: modulation by stressors. Am. J. Physiol., 2009, 296, G992-G1002.
235. Nozu, T.; Takakusaki, K.; Okumura, T. A balance theory of peripheral corticotropin-releasing factor receptor type 1 and type 2 signaling to induce colonic contractions and visceral hyperalgesia in rats. Endocrinology, 2014, 155, 4655-4664.
236. Andoh, K.; Kimura, T.; Saeki, I.; Tabata, R.; Yamazaki, S.; Eguchi, I.; Hanazuka, M.; Horii, D.; Munt, P.L.; Davis, A.S.;. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human). Arzneimittelforschun, 1994, 44, 715-726.
237. Shannon, M.H.; Bihm, C.C.; Short, W.J.; Burks, T.F.; Williams, C. L. Interactions of oxytocin and vasopressin with CRF on the rat colon. Neuropeptides, 1997, 31, 94-98.
238. Rivier, J.; Gulyas, J.; Kunitake, K.; DiGruccio, M.; Cantle, J.; Perrin, MH.; Donaldson, C.; Vaughan, J.; Million M; Gourcerol, G.; Adelson, D.; Rivier, C.; Taché, Y.; Vale, W. Stressin1-A, a potent corticotropin releasing factor receptor 1 (CRF1)-selective peptide agonist. J. Med. Chem., 2007, 50, 1668-1674.
239. Tezval, H.; Jahn, O.; Todorovic, C.; Sasse, A.; Eckart, K.; Spiess, J. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model. Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 9468-9473.
240. Larauche, M.; Gourcerol, G.; Wang, L.; Pambukchian, K.; Brunnhuber, S.; Adelson, D.W.; Rivier, J.; Million, M.; Taché, Y. Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways. Am. J. Physiol., 2009, 297, G215-G227.
241. Million, M.; Wang, L.; Wang, Y.; Adelson, D.W.; Yuan, P.Q.; Maillot, C.; Coutinho, S.V.; McRoberts, J.A.; Bayati, A.; Mattsson, H.; Wu, V.S.; Wei, J.Y.; Rivier, J.; Vale, W.; Mayer, E. A.; Taché, Y. CRF2 receptor activation prevents colorectal distension-induced visceral pain and spinal ERK1/2 phosphorylation in rats. Gut, 2006, 55, 172-181.
242. Mancinelli, R.; Azzena, G.B.; Diana, M.; Forgione, A.; Fratta, W. In vitro excitatory actions of corticotropin-releasing factor on rat colonic motility. J. Auton. Pharmacol., 1998, 18, 319-324.
243. Liu, S.; Gao, X.; Gao, N.; Wang, X.; Fang, X.; Hu, H.Z.; Wang, G. D.; Xia, Y.; Wood, J.D. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system. J. Comp Neurol., 2005, 481, 284-298.
244. Liu, S.; Ren, W.; Qu, M.H.; Bishop, G.A.; Wang, G.D.; Wang, X. Y.; Xia, Y.; Wood, J.D. Differential actions of urocortins on neurons of the myenteric division of the enteric nervous system in guinea pig distal colon. Br. J. Pharmacol., 2010, 159, 222-236.
245. 1 receptor in conscious rats. Am. J. Physiol., 2002, 282, G857-G865.
246. Miampamba, M.; Million M; Yuan P-Q; Larouche, M.; Taché Y Water avoidance stress activates colonic myenteric neurons in female rats. Neuroreport, 2007, 18, 679-682.
247. Hanani, M.; Wood, J.D. Corticotropin-releasing hormone excites myenteric neurons in the guinea-pig small intestin. Eur. J. Pharmacol., 1992, 211, 23-27.
248. Keita, A.V.; Soderholm, J.D.; Ericson, A.C. Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells. Neurogastroenterol. Motil., 2010, 22, 770-772.
249. Smith, F.; Clark, J.E.; Overman, B.L.; Tozel, C.C.; Huang, J.H.; Rivier, J.E.; Blikslager, A.T.; Moeser, A.J. Early weaning stress impairs development of mucosal barrier function in the porcine intestine. Am. J. Physiol., 2010, 298, G352-G363.
250. La, J.H.; Sung, T.S.; Kim, H.J.; Kim, T.W.; Kang, T.M.; Yang, I. S. Peripheral corticotropin releasing hormone mediates post-inflammatory visceral hypersensitivity in rats. World J. Gastroenterol., 2008, 14, 731-736.
251. van den Wijngaard, R.M.; Stanisor, O.I.; van Diest, S.A.; Welting, O.; Wouters, M.M.; de Jonge, W.J.; Boeckxstaens, G.E. Peripheral alpha-helical CRF (9-41) does not reverse stress-induced mast cell dependent visceral hypersensitivity in maternally separated rats. Neurogastroenterol. Motil., 2012, 24, 274-e111.
252. Ait-Belgnaoui, A.; Bradesi, S.; Fioramonti, J.; Theodorou, V.; Buéno, L. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase. Pain, 2005, 113, 141-147.
253. Soderholm, J.D.; Perdue, M.H. II. Stress and intestinal barrier function. Am. J. Physiol., 2001, 280, G7-G13.
254. Barreau, F.; Cartier, C.; Leveque, M.; Ferrier, L.; Moriez, R.; Laroute, V.; Rosztoczy, A.; Fioramonti, J.; Buéno, L. Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay. J. Physiol., 2007, 580, 347-356.
255. Saunders, P.R.; Kosecka, U.; McKay, D.M.; Perdue, M.H. Acute stressors stimulate ion secretion and increase epithelial permeability in rat intestine. Am. J. Physiol., 1994, 267, G794-G799.
256. Santos, J.; Saunders, P.R.; Hanssen, N.P.M.; Yang, P.C.; Yates, D.; Groot, J.A.; Perdue, M.H. Corticotropin-releasing hormone mimics stress-induced rat colonic epithelial pathophysiology in the rat. Am. J. Physiol., 1999, 277, G391-G399.
257. Teitelbaum, A.A.; Gareau, M.G.; Jury, J.; Yang, P.C.; Perdue, M. H. Chronic peripheral administration of corticotropin-releasing factor causes colonic barrier dysfunction similar to psychological stress. Am. J. Physiol., 2008, 295, G452-G459.
258. Saunders, P.R.; Santos, J.; Hanssen, N.P.; Yates, D.; Groot, J.A.; Perdue, M.H. Physical and psychological stress in rats enhances colonic epithelial permeability via peripheral CRH. Dig. Dis. Sci., 2002, 47, 208-215.
259. Soderholm, J.D.; Yates, D.A.; Gareau, M.G.; Yang, P.C.; MacQueen, G.; Perdue, M.H. Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress. Am. J. Physiol., 2002, 283, G1257-G1263.
260. Stead, R.H.; Dixon, M.F.; Bramwell, N.H.; Riddell, R.H.; Bienenstock, J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology, 1989, 97, 575-585.
261. Overman, E.L.; Rivier, J.E.; Moeser, A.J. CRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-alpha. PLoS. One., 2012, 7, e39935.
262. Sengupta, J. N. Visceral pain: the neurophysiological mechanism. Handb. Exp. Pharmacol., 2009, 31-74.
263. Cervero, F.; Laird, J.M. Understanding the signaling and transmission of visceral nociceptive events. J. Neurobiol., 2004, 61, 45-54.
264. Mawe, G.M.; Coates, M.D.; Moses, P.L. Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment. Pharmacol. Ther., 2006, 23, 1067-1076.
265. von Mentzer, B.; Murata, Y.; Ahlstedt, I.; Lindstrom, E.; Martinez, V. Functional CRF receptors in BON cells stimulate serotonin release. Biochem. Pharmacol. 2007, 73, 805-813.
266. Theoharides, T.C.; Donelan, J.M.; Papadopoulou, N.; Cao, J.; Kempuraj, D.; Conti, P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol. Sci., 2004, 25, 563-568.
267. Wallon, C.; Yang, P.C.; Keita, A.V.; Ericson, A.C.; McKay, D.M.; Sherman, P.M.; Perdue, M.H.; Soderholm, J.D. Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro. Gut, 2008, 57, 50-58.
268. Wallon, C.; Soderholm, J.D. Corticotropin-releasing hormone and mast cells in the regulation of mucosal barrier function in the human colon. Ann. N.Y. Acad. Sci., 2009, 1165, 206-210.
269. Chatzaki, E.; Anton, P.A.; Million, M.; Lambropoulou, M.; Constantinidis, T.; Kolios, G.; Taché, Y.; Grigoriadis, D.E. Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis. World J. Gastroenterol., 2013, 19, 1416-1423.
270. Kawahito, Y.; Sano, H.; Chrousos, G.P.; Wilder, R.L.; Yuri, K.; Katawa, M.; Kato, H.; Kondo, M. The production of corticotropin-releasing hormone in normal human colonic mucosal cells (enterochromaffin cells). Gastroenterology, 1993, 104, A1044.
271. Kempuraj, D.; Papadopoulou, N.G.; Lytinas, M.; Huang, M.; Kandere-Grzybowska, K.; Madhappan, B.; Boucher, W.; Christodoulou, S.; Athanassiou, A.; Theoharides, T.C. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology, 2004, 145, 43-48.
272. Saruta, M.; Takahashi, K.; Suzuki, T.; Fukuda, T.; Torii, A.; Sasano, H. Urocortin 3/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions. Peptides, 2005, 26, 1196-1206.
273. Vanuytsel, T.; van, W.S.; Vanheel, H.; Vanormelingen, C.; Verschueren, S.; Houben, E.; Salim, R.S.; Tomicronth, J.; Holvoet, L.; Farre, R.; Van, O.L.; Boeckxstaens, G.; Verbeke, K.; Tack, J. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut, 2014, 63, 1293-1299.
274. Fukudo, S.; Nomura, T.; Hongo, M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998, 42, 845-849.
275. Illum, L. Is nose-to-brain transport of drugs in man a reality? J. Pharm. Pharmacol., 2004, 56, 3-17.
276. Hallschmid, M.; Benedict, C.; Born, J.; Fehm, H.L.; Kern, W. Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man. Physiol. Behav., 2004, 83, 55-64.
277. Kern, W.; Schiefer, B.; Schwarzenburg, J.; Stange, E.F.; Born, J.; Fehm, H.L. Evidence for central nervous effects of corticotropin-releasing hormone on gastric acid secretion in humans. Neuroendocrinology, 1997, 65, 291-298.
278. Pritchard, S.E.; Garsed, K.C.; Hoad, C.L.; Lingaya, M.; Banwait, R.; Thongborisute, W.; Roberts, E.; Costigan, C.; Marciani, L.; Gowland, P.A.; Spiller, R.C. Effect of experimental stress on the small bowel and colon in healthy humans. Neurogastroenterol. Motil., 2015, 27, 542-549.
279. Lembo, T.; Plourde, V.; Shui, Z.; Fullerton, S.; Mertz, H.; Taché, Y.; Sytnik, B.; Munakata, J.; Mayer, E. Effects of the corticotropin-releasing factor (CRF) on rectal afferent nerves in humans. Neurogastroenterol. Motil., 1996, 8, 9-18.
280. Nozu, T.; Kudaira, M. Corticotropin-releasing factor induces rectal hypersensitivity after repetitive painful rectal distention in healthy humans. J. Gastroenterol., 2006, 41, 740-744.
281. Stasi, C.; Bellini, M.; Bassotti, G.; Blandizzi, C.; Milani, S. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Tech. Coloproctol., 2014, 18, 613-621.
282. Tanaka, Y.; Kanazawa, M.; Fukudo, S.; Drossman, D. A. Biopsychosocial model of irritable bowel syndrome. J. Neurogastroenterol. Motil., 2011, 17, 131-139.
283. Taché, Y. Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology? Gut, 2004, 53 (7), 919-921.
284. Fukudo, S. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J. Gastroenterol., 2007, 42 (Suppl) 17, 48-51.
285. 1 receptors as a therapeutic target for irritable bowel syndrome. Curr. Pharm. Des., 2006, 12, 1-18.
286. Williams, J.P. Corticotropin-releasing factor 1 receptor antagonists: a patent review. Expert. Opin. Ther. Pat., 2013, 23, 1057-1068.
287. Chen, C. Recent advances in small molecule antagonists of the corticotropin-releasing factor type-1 receptor-focus on pharmacology and pharmacokinetics. Curr. Med. Chem., 2006, 13, 1261-1282.
288. Tellew, J.E.; Lanier, M.; Moorjani, M.; Lin, E.; Luo, Z.; Slee, D. H.; Zhang, X.; Hoare, S.R.; Grigoriadis, D.E.; St Denis, Y.; Di Fabio, R.; Di Modugno, E.; Saunders, J.; Williams, J.P. Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties. Bioorg. Med. Chem. Lett., 2010, 20, 7259-7264.
289. Liapakis, G.; Venihaki, M.; Margioris, A.; Grigoriadis, D.; Gkountelias, K. Members of CRF family and their receptors: from past to future. Curr. Med. Chem., 2011, 18, 2583-2600.
290. Hodgetts, K.J.; Ge, P.; Yoon, T.; Lombaert, S.D.; Brodbeck, R.; Gulianello, M.; Kieltyka, A.; Horvath, R.F.; Kehne, J.H.; Krause, J. E.; Maynard, G.D.; Hoffman, D.; Lee, Y.; Fung, L.; Doller, D. Discovery of N-(1-Ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyra zin-2-yl]amine 59 (NGD 98-2): An Orally Active Corticotropin Releasing Factor-1 (CRF-1) Receptor Antagonist. J. Med. Chem., 2011, 54, 4187-4206.
291. Kehne, J.H.; Cain, C.K. Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models. Pharmacol. Ther., 2010, 128, 460-487.
292. 2 proof-of-concept experimental model of human anxiety. J. Psychopharmacol., 2011, 25(9), 1199-1206.
293. Schmidt, M.E.; Andrews, R.D.; van der, A.P.; Brown, T.; Mannaert, E.; Steckler, T.; de Hoon, J.; Van Laere, K. Dose-dependent effects of the CRF(1) receptor antagonist R317573 on regional brain activity in healthy male subjects. Psychopharmacology (Berl), 2010, 208, 109-119.
294. Hubbard, C.S.; Labus, J.S.; Bueller, J.; Stains, J.; Suyenobu, B.; Dukes, G.E.; Kelleher, D.L.; Tillisch, K.; Naliboff, B.D.; Mayer, E. A. Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain. J. Neurosci., 2011, 31, 12491-12500.
295. Bouin, M.; Plourde, V.; Boivin, M.; Riberdy, M.; Lupien, F.; Laganiere, M.; Verrier, P.; Poitras, P. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology, 2002, 122, 1771-1777.
296. North, C.S.; Hong, B.A.; Alpers, D.H. Relationship of functional gastrointestinal disorders and psychiatric disorders: Implications for treatment. World J. Gastroenterol., 2007, 13, 2020-2027.
297. Sagami, Y.; Shimada, Y.; Tayama, J.; Nomura, T.; Satake, M.; Endo, Y.; Shoji, T.; Karahashi, K.; Hongo, M.; Fukudo, S. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut, 2004, 53, 958-964.
298. Tayama, J.; Sagami, Y.; Shimada, Y.; Hongo, M.; Fukudo, S. Effect of alpha-helical CRH on quantitative electroencephalogram in patients with irritable bowel syndrome. Neurogastroenterol. Mot., 2007, 19, 471-483.
299. Sweetser, S.; Camilleri, M.; Linker Nord, S.J.; Burton, D.D.; Castenada, L.; Croop, R.; Tong, G.; Dockens, R.; Zinsmeister, A. R. Do Corticotropin Releasing Factor-1 Receptors Influence Colonic Transit and Bowel Function in Females with Irritable Bowel Syndrome? Am. J. Physiol. Gastrointest. Liver. Physiol., 2009, 296(6),G1299-306.
300. Zmijewski, M.A.; Slominski, A.T. CRF1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations. J. Cell Physiol., 2009, 218, 593-602.
301. Taché, Y. Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis. Dig. Dis. Sci., 1999, 44, 79S-86S.